| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | Jul 10, 2018 | Sale | $179.43 | 1,400,000 | 251,201,990 | 2,038,920 | Jul 12, 2018, 04:45 PM | |
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | Dec 19, 2017 | Sale | $80.50 | 250,000 | 20,125,000 | 3,438,920 | Dec 20, 2017, 04:31 PM | |
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | Nov 22, 2017 | Sale | $75.00 | 500,000 | 37,500,000 | 3,688,920 | Nov 27, 2017, 07:29 PM | |
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | Jan 10, 2017 | Buy | $31.00 | 160,000 | 4,960,000 | 4,188,920 | Jan 12, 2017, 05:17 PM | |
| SYRS | Syros Pharmaceuticals, Inc. | AISLING CAPITAL III LP | 10% Owner | Jul 06, 2016 | Buy | $12.50 | 400,000 | 5,000,000 | 908,565 | Jul 06, 2016, 05:10 PM | |
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | May 17, 2016 | Buy | $21.50 | 232,558 | 4,999,997 | 4,028,920 | May 19, 2016, 04:24 PM | |
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | Dec 11, 2015 | Buy | $27.50 | 200 | 5,500 | 3,796,362 | Dec 15, 2015, 06:28 PM | |
| TTOO | T2 Biosystems, Inc. | AISLING CAPITAL III LP | 10% Owner | Dec 09, 2015 | Buy | $9.75 | 307,692 | 2,999,997 | 2,830,992 | Dec 09, 2015, 04:47 PM | |
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | Nov 17, 2015 | Buy | $26.50 | 265,000 | 7,022,500 | 3,796,182 | Nov 19, 2015, 05:34 PM | |
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | Nov 12, 2015 | Buy | $27.65 | 76,714 | 2,121,319 | 3,529,207 | Nov 16, 2015, 05:16 PM | |
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | Nov 13, 2015 | Buy | $27.47 | 1,955 | 53,704 | 3,531,182 | Nov 16, 2015, 05:16 PM | |
| VSAR | Versartis, Inc. | AISLING CAPITAL III LP | 10% Owner | Jan 27, 2015 | Buy | $17.25 | 145,000 | 2,501,250 | 2,139,568 | Jan 29, 2015, 05:10 PM | |
| AGRX | AGILE THERAPEUTICS INC | AISLING CAPITAL III LP | Director | Jan 23, 2015 | Buy | $5.85 | 811,966 | 4,750,001 | 2,983,797 | Jan 27, 2015, 04:25 PM | |
| TTOO | T2 Biosystems, Inc. | AISLING CAPITAL III LP | 10% Owner | Aug 12, 2014 | Buy | $11.00 | 454,545 | 4,999,995 | 2,523,300 | Aug 14, 2014, 04:34 PM | |
| LOXO | Loxo Oncology, Inc. | AISLING CAPITAL III LP | 10% Owner | Aug 06, 2014 | Buy | $13.00 | 413,077 | 5,370,001 | 3,452,493 | Aug 06, 2014, 04:11 PM | |
| TRXC | TRANSENTERIX INC. | AISLING CAPITAL III LP | 10% Owner | Apr 21, 2014 | Buy | $4.00 | 1,037,767 | 4,151,068 | 8,335,819 | Apr 23, 2014, 04:48 PM | |
| VSAR | Versartis, Inc. | AISLING CAPITAL III LP | 10% Owner | Mar 26, 2014 | Buy | $21.00 | 60,000 | 1,260,000 | 1,994,568 | Mar 27, 2014, 06:34 PM | |
| DRTX | Durata Therapeutics, Inc. | AISLING CAPITAL III LP | 10% Owner | Mar 20, 2014 | Sale | $15.74 | 98,000 | 1,542,589 | 3,032,824 | Mar 21, 2014, 08:08 PM | |
| DRTX | Durata Therapeutics, Inc. | AISLING CAPITAL III LP | 10% Owner | Mar 21, 2014 | Sale | $15.57 | 2,649 | 41,255 | 3,030,175 | Mar 21, 2014, 08:08 PM | |
| ZLTQ | Zeltiq Aesthetics Inc | AISLING CAPITAL III LP | 10% Owner | Nov 14, 2013 | Sale | $12.22 | 575,000 | 7,026,500 | 3,597,742 | Nov 15, 2013, 04:37 PM | |
| DRTX | Durata Therapeutics, Inc. | AISLING CAPITAL III LP | 10% Owner | Jul 24, 2012 | Buy | $9.00 | 1,111,111 | 9,999,999 | 3,130,824 | Jul 25, 2012, 05:08 PM | |
| ZLTQ | Zeltiq Aesthetics Inc | AISLING CAPITAL III LP | 10% Owner | Oct 24, 2011 | Buy | $13.00 | 769,231 | 10,000,003 | 4,172,742 | Oct 25, 2011, 06:53 PM |
Menu